# Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD

> **NCT02634177** · NA · COMPLETED · sponsor: **Genomind, LLC** · enrollment: 305 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **GENETIC:** Assay-guided treatment (AGT)
- **OTHER:** Treatment-as-usual (TAU)

## Key facts

- **NCT ID:** NCT02634177
- **Lead sponsor:** Genomind, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-07-25
- **Final completion:** 2017-07-25
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2020-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02634177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02634177, "Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02634177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*